Author/Authors :
Nassiri-Koopaei, Nasser tehran university of medical sciences tums - Faculty of Pharmacy - Department of Pharmacoeconomics and Pharmaceutical Administration, تهران, ايران , Majdzadeh, Reza tehran university of medical sciences tums - School of Public Health, Knowledge Utilization Research Center, تهران, ايران , Kebriaeezadeh, Abbas tehran university of medical sciences tums - Faculty of Pharmacy, Pharmaceutical Policy Research Center - Department of Pharmacoeconomics and Pharmaceutical Administration, تهران, ايران , Rashidian, Arash tehran university of medical sciences tums - School of Public Health, Knowledge Translation Research Center - Department of Health Management and Economics, تهران, ايران , Tabatabai Yazdi, Mojtaba tehran university of medical sciences tums - Faculty of Pharmacy - Department of Pharmaceutical Biotechnology, تهران, ايران , Nedjat, Saharnaz tehran university of medical sciences tums - School of Public Health, Knowledge Utilization Research Center, تهران, ايران , Nikfar, Shekoufeh tehran university of medical sciences tums - Faculty of Pharmacy, Pharmaceutical Policy Research Center - Department of Pharmacoeconomics and Pharmaceutical Administration, تهران, ايران
Abstract :
Background: The objective of this study was to investigate the application of the university research findings or commercialization of the biopharmaceutical knowledge in Iran and determine the challenges and propose some solutions. Results: A qualitative study including 19 in-depth interviews with experts was performed in 2011 and early 2012. National Innovation System (NIS) model was employed as the study design. Thematic method was applied for the analysis. The results demonstrate that policy making, regulations and management development are considered as fundamental reasons for current commercialization practice pattern. It is suggested to establish foundation for higher level documents that would involve relating bodies and provide them operational guidelines for the implementation of commercialization incentives. Conclusions: Policy, regulations and management as the most influential issue should be considered for successful commercialization. The present study, for the first time, attempts to disclose the importance of evidence input for measures in order to facilitate the commercialization process by the authorities in Iran. Overall, the NIS model should be considered and utilized as one of the effective solutions for commercialization.
